{
    "Trade/Device Name(s)": [
        "Tina-quant Cystatin C",
        "Cfas (Calibrator for automated systems) Cystatin C",
        "Cystatin C Control Set"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K080811",
    "Predicate Device Reference 510(k) Number(s)": [
        "K041627"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NDY",
        "JIT",
        "JJX"
    ],
    "Summary Letter Date": "March 21, 2008",
    "Summary Letter Received Date": "March 24, 2008",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1225"
    ],
    "Regulation Name(s)": [
        "Test, Cystatin C"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "tdm",
        "misc"
    ],
    "Analyte(s)": [
        "Cystatin C"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Lithium-heparin plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Hitachi 917",
        "MODULAR P",
        "cobas c 501"
    ],
    "Method(s)/Technology(ies)": [
        "Immunoturbidimetric assay",
        "Particle enhanced immunoturbidimetric assay"
    ],
    "Methodologies": [
        "Quantitative determination",
        "Immunoturbidimetry"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Roche Tina-quant Cystatin C immunoturbidimetric assay, calibrator, and control set for cystatin C measurement on Roche clinical chemistry analyzers",
    "Indications for Use Summary": "Quantitative in vitro determination of cystatin C in human serum and lithium-heparin plasma as an aid in the diagnosis and treatment of renal diseases using Roche automated clinical chemistry analyzers; includes calibrator for method calibration and control set for quality control.",
    "fda_folder": "Clinical Chemistry"
}